Price cut of Alimta likely have positive impact to Lilly Korea

Lilly Korea will cut the price of a month's supply of 500 mL Alimta (Pemetrexed) from 1,304,620 won to 1,148,011 won, a 17.6% dip, from April 1 this year. Instead, patients with non-small cell lung cancer will be also reimbursable with Alimta.

The price cut is a good news for all patients and ourselves, as the measurable improvement in people taking Alimta is a significant advance in Mesothe...